🇺🇸 FDA
Pipeline program

Lubiprostone

MS-LUB-106

Phase 1 small_molecule completed

Quick answer

Lubiprostone for Chronic Constipation, Methanogenesis is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Constipation, Methanogenesis
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials